Related Experiment Video

Updated: Jun 17, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

[Effect of signal transduction inhibitors on human endometrial carcinoma cells with differential PTEN gene

Lan Xiao1, Yue-bo Yang, Hui-min Shen

  • 1Department of Gynecology, Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China.

Zhonghua Fu Chan Ke Za Zhi
|January 19, 2010
PubMed
Abstract

Insights

Loss of PTEN in endometrial cancer cells enhances apoptosis and G1 phase arrest, inhibiting proliferation. This sensitivity is linked to signal transduction inhibitors, offering potential therapeutic insights.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • The PTEN gene plays a crucial role in cell growth and tumor suppression.
  • Dysregulation of PTEN is implicated in various cancers, including endometrial carcinoma.
  • Signal transduction inhibitors are being explored as targeted therapies for cancer.

Purpose of the Study:

  • To investigate the effects of signal transduction inhibitors on human endometrial carcinoma cells with varying PTEN gene expression.
  • To determine the impact of PTEN status on cellular apoptosis, proliferation, and cell cycle progression in response to specific inhibitors.

Main Methods:

  • PTEN gene expression was manipulated in endometrial carcinoma cell lines (HEC-1A and Ishikawa) using antisense oligonucleotides and pcDNA3.1/PTEN vectors.
  • PTEN protein expression levels were confirmed using confocal spectral microscopy.
  • Cells with altered PTEN expression were treated with signal transduction inhibitors (RG-14620, SB203580, and rapamycin).
  • Apoptosis, cell cycle, and cell viability were assessed using Hoechst 33258 staining, flow cytometry, and MTT assays.

Main Results:

  • PTEN protein expression was successfully modulated in the HEC-1A and Ishikawa cell lines.
  • Treatment with RG-14620, SB203580, and rapamycin induced significant morphological changes indicative of apoptosis in PTEN-null and wild-type cells.
  • SB203580 notably increased apoptosis and G1 phase cell populations in PTEN-null and wild-type cells, while decreasing cell viability.

Conclusions:

  • Loss of PTEN in endometrial carcinoma cells appears to enhance G1 phase arrest and apoptotic effects.
  • Inhibition of cell proliferation is observed in PTEN-deficient cells, correlating with increased sensitivity to specific signal transduction inhibitors.
  • These findings suggest that PTEN status influences endometrial carcinoma cell response to targeted therapies.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...